Search

everythinglearnresearchcommunity

for

Search:↓

After severe COVID-19, lung damage can improve, detected effectively by lung-ultrasound, and high pressure support during hospitalization can increase lung artery size. Also, about 22% of patients had lung blood clots, and when treated, they recovered faster.

Many COVID-19 patients still have symptoms like fatigue and loss of taste or smell a month after diagnosis.

A woman developed skin lesions after PRP injections, possibly linked to COVID-19 infection and vaccination.

COVID-19 can cause various skin issues in children, mostly not severe, with chilblain-like lesions being common, especially in adolescents.

Most skin reactions to COVID-19 vaccines in India were mild and not a reason to avoid vaccination.

COVID-19 and its vaccines can cause various skin issues, with urticaria being the most common.

A man developed neurological issues from SARS-CoV-2 without severe breathing problems, worsening to death.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

The COVID-19 pandemic led to fewer skin checks and skin cancer diagnoses in Australia in 2020.

The COVID-19 pandemic led to more young people getting red stretch marks due to lifestyle changes like less activity and quick weight gain.

COVID-19 can cause skin issues like hives, rashes, and chickenpox-like eruptions, with women aged 31-40 being the most affected.

Men are more likely to have severe COVID-19 cases and fatalities than women due to factors like lifestyle, aging, and biological differences.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

COVID-19 reduced dermatology visits by 30.4%, with more male patients and increased cases of psoriasis, bullous diseases, and melanoma.

Higher dihydrotestosterone may be linked to more inflammation in COVID-19 patients with low testosterone.

An 80-year-old man with COVID-19 also had constrictive pericarditis, possibly due to an autoimmune or immunoglobulin related disease, and improved after surgery.

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.

Insulin resistance linked to obesity may increase COVID-19 severity.

Anabolic steroid users may face higher risk of severe COVID-19.

Some patients on immunosuppressants had a weaker immune response to the Sinovac-CoronaVac COVID-19 vaccine.

Proxalutamide improved blood markers related to inflammation, immune response, and clotting in COVID-19 patients, potentially reducing hospitalizations.

COVID-19 changed dermatology by increasing telemedicine and highlighting healthcare disparities.

Some drugs may help treat both COVID-19 and radiation injury.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.

Androgens and a high-fat diet may increase the risk of severe COVID-19 in women with PCOS by upregulating certain proteins in the heart and kidneys.

The AndroCoV Clinical Scoring is an accurate, easy, and free way to diagnose COVID-19 without a lab test.

Proxalutamide improved recovery, lowered death rates, and reduced hospital stay for COVID-19 patients.

The conclusion is that certain genetic factors and blood types may affect COVID-19 severity, but changes in ACE2 and TMPRSS2 genes are not clearly linked to it.